Ostalska-Nowicka D, Zachwieja J, Nowicki M, Kaczmarek E, Siwińska A, Witt M
Department of Paediatric Cardiology and Nephrology, Poznań University of Medical Sciences, Poznań, Poland.
Histopathology. 2007 Oct;51(4):468-76. doi: 10.1111/j.1365-2559.2007.02818.x.
Galectin-1 is an endogenous lectin that specifically binds to beta-galactoside structures. It has been associated with developmental mechanisms ranging from differentiation to apoptosis and exerts immunoregulatory functions in autoimmune diseases. The aim was to determine the immunohistochemical expression of galectin-1 in renal biopsy specimens of children with primary idiopathic proteinuric glomerulopathies.
We examined 18 children with minimal change disease (MCD), 30 with diffuse mesangial proliferation (DMP) and 11 with focal segmental glomerulosclerosis (FSGS). An indirect immunohistochemical protocol using a polyclonal antibody directed against galectin-1 was applied. Galectin-1 was detected in renal podocytes in DMP and FSGS cases, while control glomeruli and MCD were negative. Galectin-1 immunoreactivity was found within parietal epithelial cells in patients with FSGS.
These results suggest a possible role for galectin-1 in the pathogenesis of primary glomerulopathies in children as a kind of podocyte-related self-protective activity and probably involvement of epithelial cells of Bowman's capsule in inflammatory processes. Immunohistochemistry using galectin-1 antibodies may further be helpful in histological distinction between MCD and DMP.
半乳糖凝集素-1是一种内源性凝集素,可特异性结合β-半乳糖苷结构。它与从分化到凋亡的发育机制相关,并在自身免疫性疾病中发挥免疫调节功能。本研究旨在确定原发性特发性蛋白尿性肾小球病患儿肾活检标本中半乳糖凝集素-1的免疫组化表达情况。
我们检查了18例微小病变病(MCD)患儿、30例弥漫性系膜增生(DMP)患儿和11例局灶节段性肾小球硬化(FSGS)患儿。采用针对半乳糖凝集素-1的多克隆抗体进行间接免疫组化检测。在DMP和FSGS病例的肾足细胞中检测到半乳糖凝集素-1,而对照肾小球和MCD为阴性。在FSGS患者的壁层上皮细胞中发现了半乳糖凝集素-1免疫反应性。
这些结果表明,半乳糖凝集素-1在儿童原发性肾小球病的发病机制中可能发挥作用,作为一种与足细胞相关的自我保护活性,并且可能鲍曼囊上皮细胞参与了炎症过程。使用半乳糖凝集素-1抗体进行免疫组化可能有助于MCD和DMP的组织学鉴别。